Vertex Pharmaceuticals's diluted shares was 258M shares for fiscal year 2025 (the twelve months to 31 Dec 2025), unchanged from fiscal 2024.
In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was 255M shares, down 0.9% from a year earlier.
From Vertex Pharmaceuticals's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 3 Nov 2026.
Fiscal 2025
258M
0.0%
Q3 FY2026
255M
−0.9% on a year
Growth over 9 years
+0.6%
a year, FY 2016–FY 2025
Diluted shares by fiscal year
Change on the year before, under each year. From FY 2016 to FY 2025, Vertex Pharmaceuticals's diluted shares went from 245M shares to 258M shares, a compound annual change of +0.6%; the highest was 263M shares in FY 2020.
Vertex Pharmaceuticals diluted shares, fiscal years
Period
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Diluted shares
245M
253M
259M
261M
263M
260M
259M
261M
258M
258M
Period end
31 Dec 2016
31 Dec 2017
31 Dec 2018
31 Dec 2019
31 Dec 2020
31 Dec 2021
31 Dec 2022
31 Dec 2023
31 Dec 2024
31 Dec 2025
Diluted shares by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
Vertex Pharmaceuticals's other figures
Diluted shares of comparable companies
Everything on VRTX, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.